Cart summary

You have no items in your shopping cart.

Birinapant

SKU: orb1226656

Description

Birinapant is a SMAC mimetic antagonist, mostly to cIAP1 with Kd of <1 nM, less potent to XIAP. Phase 2.(In Vitro):Birinapant (TL32711) (30-10000 nM; 24 hours) significantly decreases the viability of SUM190 cells in a dose-dependent manner.Birinapant (TL32711) (30-1000 nM; 4 hours) shows a significant decrease in cIAP1 levels and enhanced PARP cleavage, and induces apoptosis.Birinapant (TL32711) binds with high affinity to the isolated BIR3 domains of cIAP1, cIAP2, and XIAP and the single BIR domain of ML-IAP and rapidly degrades TRAF2-bound cIAP1 and cIAP2 thereby inhibiting TNF-mediated NF-κB activation.(In Vivo):Birinapant (TL32711) (30 mg/kg; i.p.; every third day (*5)) shows antitumor efficacy and are devoid of overt toxicity in preclinical models.

Images & Validation

Key Properties

CAS Number1260251-31-7
MW806.94
Purity>98% (HPLC)
FormulaC42H56F2N8O6
SMILESC[C@H](NC)C(N[C@@H](CC)C(N1[C@H](CC2=C(C(N3)=C(C[C@H]4N(C([C@@H](NC([C@@H](NC)C)=O)CC)=O)C[C@@H](O)C4)C5=C3C=C(F)C=C5)NC6=C2C=CC(F)=C6)C[C@H](O)C1)=O)=O
TargetIAP
SolubilityDMSO:100 mg/mL (123.92 mM); Ethanol:55 mg/mL (68.15 mM); Water:<1 mg/mL (<1 mM)

Bioactivity

In Vivo
Animal model: Female athymic nude mice (low-passage, patient-derived xenotransplant models of ovarian cancer, colorectal cancer, and melanoma). Dosage: 30 mg/kg. Administration: Intraperitoneal injection; every third day (*5). Result: Resulted in inhibition of tumor growth.
In Vitro
Cell Viability Assay Cell line: TRAIL-resistant SUM190 IBC cells. Concentration: 30, 100, 300, 1000, 10000 nM. Incubation time: 24 hours. Result: Significantly decreased the viability of SUM190 cells in a dose-dependent manner. Western blot analysis. Cell line: SUM190 cells. Concentration: 30, 300, 1000 nM. Incubation time: 4 hours. Result: Showed a significant decrease in cIAP1 levels and enhanced PARP cleavage.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

TL-32711

Similar Products

  • Birinapant [orb1301184]

    99.78%

    1260251-31-7

    806.94

    C42H56F2N8O6

    100 mg, 25 mg, 1 ml x 10 mM (in DMSO), 1 mg, 2 mg, 5 mg, 10 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Birinapant (orb1226656)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

200 mg
500 mg
2 mg
$ 80.00
5 mg
$ 110.00
10 mg
$ 170.00
25 mg
$ 260.00
50 mg
$ 350.00
100 mg
$ 610.00